1. Home
  2. FGBI vs NSRX Comparison

FGBI vs NSRX Comparison

Compare FGBI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$8.09

Market Cap

77.4M

Sector

Finance

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$7.00

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FGBI
NSRX
Founded
1934
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.4M
63.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
FGBI
NSRX
Price
$8.09
$7.00
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
26.7K
9.4K
Earning Date
01-30-2026
02-15-2026
Dividend Yield
0.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,036,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$5.90
52 Week High
$10.85
$9.99

Technical Indicators

Market Signals
Indicator
FGBI
NSRX
Relative Strength Index (RSI) 83.87 N/A
Support Level $7.50 N/A
Resistance Level $7.75 N/A
Average True Range (ATR) 0.37 0.00
MACD 0.18 0.00
Stochastic Oscillator 99.67 0.00

Price Performance

Historical Comparison
FGBI
NSRX

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: